Almac Discovery Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Almac Discovery Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10903
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Almac Discovery Ltd (Almac Discovery) a subsidiary of Almac Group Ltd is a healthcare service provider that discovers and develops drugs for the treatment of cancer. The company develops drugs, small molecule and therapeutic peptide, biomarkers and diagnostic tools. It provides early drug discovery and development services such as target finding, phase I clinical trials, lead optimization, preclinical development and clinical development. Almac Discovery’s pipeline products include ALM201, a microtubule binding agent in Phase 1 for the treatment of solid tumours; ALM301, a allosteric Akt inhibitor; and Wee-1 Inhibitor for the control of cell cycle. The company also conducts research on DNA repair and deubiquitinating enzymes. Almac Discovery is headquartered in Craigavon, the UK.

Almac Discovery Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Almac Discovery Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Almac Discovery and Royal College of Surgeons in Ireland Enter into Research Agreement 10
McClay Foundation, Almac Discovery and University of Ulster Enter into Research Agreement 11
Elasmogen and Almac Discovery Enter into Co-Development Agreement 12
Almac Discovery Enters Into Agreement With Queen’s University Belfast For Drug Discovery 13
Licensing Agreements 15
Debiopharm International Enters into Licensing Agreement with Almac Discovery 15
Genentech Enters into Licensing Agreement with Almac Discovery 16
Almac Discovery Enters Into Licensing Agreement With Shin Poong Pharma For ALM201 17
Almac Discovery Ltd – Key Competitors 18
Almac Discovery Ltd – Key Employees 19
Almac Discovery Ltd – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Government and Public Interest 21
Aug 06, 2018: Almac discovery, Elasmogen and Innovate UK collaborate to develop VNAR based oncology platform 21
Product News 22
Dec 04, 2017: Almac Discovery Publishes USP7 Inhibitors From UbiPlex Platform 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Almac Discovery Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Almac Discovery Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Almac Discovery and Royal College of Surgeons in Ireland Enter into Research Agreement 10
McClay Foundation, Almac Discovery and University of Ulster Enter into Research Agreement 11
Elasmogen and Almac Discovery Enter into Co-Development Agreement 12
Almac Discovery Enters Into Agreement With Queen’s University Belfast For Drug Discovery 13
Debiopharm International Enters into Licensing Agreement with Almac Discovery 15
Genentech Enters into Licensing Agreement with Almac Discovery 16
Almac Discovery Enters Into Licensing Agreement With Shin Poong Pharma For ALM201 17
Almac Discovery Ltd, Key Competitors 18
Almac Discovery Ltd, Key Employees 19

List of Figures
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Almac Discovery Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Distell Group Limited:企業の戦略・SWOT・財務情報
    Distell Group Limited - Strategy, SWOT and Corporate Finance Report Summary Distell Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Barkers (Northallerton) Limited:企業の戦略的SWOT分析
    Barkers (Northallerton) Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Kronos Worldwide Inc (KRO):企業の財務・戦略的SWOT分析
    Kronos Worldwide Inc (KRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Service Corporation International (SCI):企業の財務・戦略的SWOT分析
    Service Corporation International (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • QBE Insurance Group Limited:戦略・SWOT・企業財務分析
    QBE Insurance Group Limited - Strategy, SWOT and Corporate Finance Report Summary QBE Insurance Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Top Image Systems Ltd (TISA):企業の戦略的SWOT分析
    Top Image Systems Ltd (TISA) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Advent Software, Inc.:企業の戦略的SWOT分析
    Advent Software, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Harman International Industries, Incorporated:企業のM&A・事業提携・投資動向
    Harman International Industries, Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Harman International Industries, Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, …
  • Vitasoy International Holdings Limited:企業の戦略・SWOT・財務情報
    Vitasoy International Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Vitasoy International Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Cisco Systems, Inc.:企業の戦略・SWOT・財務分析
    Cisco Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cisco Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Litha Healthcare Group Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Litha Healthcare Group Ltd (Litha Healthcare), formerly Myriad Medical Holdings Limited, a subsidiary of Endo International plc is a healthcare company that provides its services to public and private hospitals, pharmacies, general, allied practitioners, and government healthcare programmes. …
  • Sammons Enterprises Inc:企業の戦略・SWOT・財務情報
    Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Canadian National Railway Co:戦略・SWOT・企業財務分析
    Canadian National Railway Co - Strategy, SWOT and Corporate Finance Report Summary Canadian National Railway Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • National Grid USA Service Co Inc:企業の戦略的SWOT分析
    National Grid USA Service Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • PPL Corporation:企業の戦略・SWOT・財務情報
    PPL Corporation - Strategy, SWOT and Corporate Finance Report Summary PPL Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Smerud Medical Research International AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Smerud Medical Research International AS (Smerud Medical) is a contract research organization that offers drug development services. The company conducts clinical trials to the pharmaceutical and biotechnology companies for improving new medical compounds. It provides services such as clinic …
  • Noble Energy Inc (NBL):企業の財務・戦略的SWOT分析
    Noble Energy Inc (NBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Endologix Inc (ELGX):医療機器:M&Aディール及び事業提携情報
    Summary Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). The company’s AAA p …
  • Mitsubishi Chemical Holdings Corp (4188):企業の財務・戦略的SWOT分析
    Mitsubishi Chemical Holdings Corp (4188) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Formula Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Formula Pharmaceuticals Inc (Formula Pharmaceuticals) is an oncology company that develops chimeric antigen receptor (CAR) immunotherapy for oncology and autoimmune diseases. The company’s pipeline products include CIK-CAR.CD19, used as B-lymphocyte surface antigen; CIK-CAR.CD33, used for th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆